OneChain Immunotherapeutics
PrivateLast Round
Grant
Feb 29, 2024
Total Funding Raised
$7.55M
Company Overview
OneChain Immunotherapeutics is a biotechnology company that develops CAR-T therapies for the treatment of oncological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
CAR-T therapyChimeric Antigen Receptor T-cellcell therapycancer immunotherapyCD1a targetT-cell acute lymphoblastic leukemiaT-ALLOrphan Drug Designationleukemia treatmentliving drugclinical-stage biotechallogeneic T-cell platformgamma-delta T-cellsγδ T-cellsGlioblastoma multiformeGBMin vivo CAR-T
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OneChain Immunotherapeutics Comps
Public and private peers based on sector, stage, and business model.
OneChain Immunotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 29, 2024 | ||||
| VC Round | Jun 22, 2023 | ||||
| Grant | Feb 23, 2023 | ||||
| Pre Seed | Jul 20, 2020 |
Key People
Founding team and executive leadership
OneChain Immunotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| Nara Capital | VC Round |
| CDTI Innvierte Program | Pre Seed |
| Clave Capital | VC Round |
| Center for Technological Development and Innovation | VC Round |
| Invivo Partners | VC Round |
| Invivo Ventures | Pre Seed |
OneChain Immunotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OneChain Immunotherapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersBarcelona
Employee Range21
Year Founded2020
Last FundingFeb 29, 2024
